Author

Hideki Tani

National Institute of Infectious DiseasesORCID 0000-0002-6309-277XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Hideki Tani1 paper

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Atsushi YamashitaiD· 1 shared Eigo KawaharaiD· 1 shared Emiko Yamazaki· 1 shared Junki MaruyamaiD· 1 shared Kentarou Waki· 1 shared Masaharu IsobeiD· 1 shared Miyuki KimuraiD· 1 shared Nobuyuki KurosawaiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Atsushi YamashitaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyeLifePeer-reviewedMay 8, 2025

Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein

Kentarou Waki, Hideki Tani, Eigo Kawahara…·Nobuyuki Kurosawa

This study shows that multimeric secretory IgA from nasal mucosa provides effective protection against SARS-CoV-2, even when monomeric IgA is non-neutralizing.

DOI 10.7554/elife.88387.3

mouseproteomics

𝕏 PostBluesky

MicrobiologyVirologyPeer-reviewedAug 10, 2023

Inhibitors of cannabinoid receptor 1 suppress the cellular entry of Lujo virus

Miyuki Kimura, Risa Matsuoka, Satoshi Taniguchi…·Hideki Tani

This study identifies CB1 receptor antagonists as inhibitors of Lujo virus entry by suppressing viral membrane fusion and reducing infectivity in vitro.

3 citations

experimental assayhost-pathogen & immune response

𝕏 PostBluesky